J. Goldman & CO LP Bridge Bio Pharma, Inc. Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
A detailed history of J. Goldman & CO LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 40,500 shares of BBIO stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
40,500Holding current value
$1.34 Million% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$834 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$829 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$498 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$411 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$204 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.89B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...